New Paradigm for Translational Modeling to Predict Long-term Tuberculosis Treatment Response.

about

New Paradigm for Translational Modeling to Predict Long-term Tuberculosis Treatment Response.

Item

http://www.wikidata.org/entity/Q38754367

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

New Paradigm for Translational ...... berculosis Treatment Response.

@en

type

Item

label

New Paradigm for Translational ...... berculosis Treatment Response.

@en

prefLabel

New Paradigm for Translational ...... berculosis Treatment Response.

@en

P1476

New Paradigm for Translational ...... berculosis Treatment Response.

@en

P2093

E L Nuermberger

http://www.w3.org/2001/XMLSchema#string

I H Bartelink

http://www.w3.org/2001/XMLSchema#string

K E Dooley

http://www.w3.org/2001/XMLSchema#string

N Strydom

http://www.w3.org/2001/XMLSchema#string

N Zhang

http://www.w3.org/2001/XMLSchema#string

P J Converse

http://www.w3.org/2001/XMLSchema#string

R J Keizer

http://www.w3.org/2001/XMLSchema#string

R M Savic

http://www.w3.org/2001/XMLSchema#string

P2860

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model

Tuneable resolution as a systems biology approach for multi-scale, multi-compartment computational models

To scale or not to scale: the principles of dose extrapolation

Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.

Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.

Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteers.

Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis.

Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis

High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.

Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis.

P304

366-379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CTS.12472

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28561946

http://www.w3.org/2001/XMLSchema#string

P932

5593171

http://www.w3.org/2001/XMLSchema#string